Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening

Tytuł :
A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening
Autorzy :
Koleva-Kolarova, R. G.
De Jonge, C.
Abu Hantash, M. K.
Zhan, Z.
Postema, E. J.
Feenstra, T. L.
Pijnappel, R. M.
Greuter, M. J.
De Bock, G. H.
Pokaż więcej
Temat :
cancer screening
death
Models, Theoretical
mass screening
Cost-Benefit Analysis
Obstetrics and Gynaecology
computer simulation
Breast Neoplasms/diagnosis
female
Early Detection of Cancer/economics
human
false positive result
radiation induced neoplasm
Mass Screening/economics
mammography
breast neoplasm
Aged
breast cancer
Middle Aged
cost-effectiveness analysis
population
Biochemistry, Genetics and Molecular Biology(all)
health care economics and organizations
conference abstract
Journal Article
adult
cost effectiveness analysis
Humans
Incidence
age
Źródło :
European Journal of Cancer, 92, S11 - S12. ELSEVIER SCI LTD
Maturitas, 109, 81 - 88. Elsevier Ireland Ltd
Koleva-Kolarova, R G, Daszczuk, A M, de Jonge, C, Hantash, M K A, Zhan, Z Z, Jan Postema, E, Feenstra, T L, Pijnappel, R M, Greuter, M J W & de Bock, G H 2018, ' A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening ', Maturitas, vol. 109, pp. 81-88 . https://doi.org/10.1016/j.maturitas.2017.12.009
European Journal of Cancer, 92(Supp. 3), S11 - S12. ELSEVIER SCI LTD
Rok publikacji :
2018
Kolekcja :
King_s_Research_Portal_enriched
NARCIS
NARCIS_enriched
King_s_Research_Portal
Opis pliku :
application/pdf
Język :
English
ISSN :
0378-5122
0959-8049
DOI :
10.1016/j.maturitas.2017.12.009
Numer akcesji :
edsair.dedup.wf.001..2b36c646e0a39de272ecfb9ce946e439
BackgroundBecause the incidence of breast cancer increases between 45 and 50 years of age, a reconsideration is required of the current starting age (typically 50 years) for routine mammography. Our aim was to evaluate the quantitative benefits, harms, and cost-effectiveness of lowering the starting age of breast cancer screening in the Dutch general population.MethodsEconomic modelling with a lifelong perspective compared biennial screening for women aged 48–74 years and for women aged 46–74 years with the current Dutch screening programme, which screen women between the ages of 50 and 74 years. Tumour deaths prevented, years of life saved (YOLS), false-positive rates, radiation-induced tumours, costs and incremental cost-effectiveness ratios (ICERs) were evaluated.ResultsStarting the screening at 48 instead of 50 years of age led to increases in: the number of small tumours detected (4.0%), tumour deaths prevented (5.6%), false positives (9.2%), YOLS (5.6%), radiation-induced tumours (14.7%), and costs (4.1%). Starting the screening at 46 instead of 48 years of age increased the number of small tumours detected (3.3%), tumour deaths prevented (4.2%), false positives (8.8%), YOLS (3.7%), radiation-induced tumours (15.2%), and costs (4.0%). The ICER was €5,600/YOLS for the 48–74 scenario and €5,600/YOLS for the 46–74 scenario.ConclusionsWomen could benefit from lowering the starting age of screening as more breast cancer deaths would be averted. Starting regular breast cancer screening earlier is also cost-effective. As the number of additional expected harms is relatively small in both the scenarios examined, and the difference in ICERs is not large, introducing two additional screening rounds is justifiable.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies